%0 Journal Article
%T Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
%A Arnaud Boyer
%A Arnaud Jeanson
%A Fabrice Barlesi
%A Laurent Greillier
%A Pascale Tomasini
%J SCIE-indexed Journal
%D 2018
%R 10.21037/jtd.2018.04.61
%X Immune Check Point inhibitors (ICIs) have demonstrated efficacy in advanced stage solid tumors including non-small cell lung cancer (NSCLC), CTLA4, programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) inhibitors being the most studied drugs
%U http://jtd.amegroups.com/article/view/20558/html